SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: ratan lal who wrote (3083)5/31/1998 10:07:00 AM
From: James Baker  Read Replies (1) | Respond to of 9523
 
<<>>>

ratan,
read the first line again.
PFE was NOT a $2 stock gamble at the time 15 years ago. That is the effective price because of all the splits that have occurred in PFE. There is a big difference between stocks selling for $2 and those selling for $30-50 and then splitting often enough to give the wise buyer an "adjusted effective price" of $2/share. You know, the $40 stock splits 2 for 1 and your adjusted price is now $20 per share etc etc etc.
Jim



To: ratan lal who wrote (3083)5/31/1998 12:25:00 PM
From: John Carpenter  Respond to of 9523
 
PFE was a large company fifteen years ago. There are other
companies that have provided similar returns, i.e. KO, G,
BMY, etc. The companies seem to have one thing in common.
They offer very consistent, almost entirely recession resistant
annual earnings growth in the mid to upper teens(20% a year or more
in some cases). These companies already had a track record
in 1983. If they perform even half as well in the next
fifteen years, as in the last, there will be some happy
campers on this thread(particularly among those that bought and
held).